Björn Hackanson

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

Julia M. Wagner, Björn Hackanson, Michael Lübbert et al. · Clinical Epigenetics · 2010 · 396 citations · Full text

Medicine, Molecular Biology, Oncology +14

Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia

Aparna Raval, Stephan M. Tanner, John C. Byrd et al. · Cell · 2007 · 368 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 289 citations · Full text

Medicine, Immunology, Oncology +7

Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1

Frank Rosenbauer, Bronwyn M. Owens, Li Yu et al. · Nature Genetics · 2005 · 241 citations

Life Sciences, Genetics, Molecular Biology +6

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Michael Lübbert, Björn Rüter, Rainer Claus et al. · Haematologica · 2011 · 231 citations · Full text

Medicine, Oncology, Pharmacology +17